SmartMS BI vs MSPT

SmartMS BI presents statistical data, generated by SmartMS (System for Monitoring, aid, registration and treatment of Multiple Sclerosis). Presented data contains information, based on Electronical Health Records (EHRs)of Bulgarian patients with MS. SmartMS EHRs have two main sources of information – health care specialists (HCPs) and patients. Advanced networking model and role based access gives patients and HCPs the best of EHRs, while keeping their data save and accessible. SmartMS BI covers MS patients, who are being treated with disease modifying drugs (DMDs) and contains information, which could be valuable for pharma companies, clinical research organizations (CROs), distributers, public funds, etc.

The Multiple Sclerosis Performance Test (MSPT) is an iPad®-based assessment tool designed to objectively quantify major motor, visual, and cognitive function for individuals with Multiple Sclerosis (MS). The MSPT App is available to healthcare and research institutions involved in clinical research related to the care of individuals with Multiple Sclerosis. The MSPT is based on the Multiple Sclerosis Functional Composite (MSFC) assessment and may include: - MyHealth, a structured patient history questionnaire - Neurological Quality of Life (Neuro-QoL) questionnaire - Processing Speed Test - Visual Memory Test - Manual Dexterity Test - Walking Speed Test The MSPT App records, stores, and displays patient data generated from the assessment modules and compares it to normative data. The MSPT is intended for use by healthcare professionals in a clinical setting and in a manner consistent with clinical judgment. It automates several tests routinely administered to MS patients. The MSPT does not provide any recommendations or conclusions related to diagnosis or treatment. Results are provided on an informational basis only.